FDA Warns 17 Companies About Illegal Alzheimer's Disease Products

Title: FDA Warns 17 Companies About Illegal Alzheimer's Disease ProductsCategory: Health NewsCreated: 2/11/2019 12:00:00 AMLast Editorial Review: 2/12/2019 12:00:00 AM
Source: MedicineNet Alzheimer - Category: Geriatrics Source Type: news

Related Links:

Autophagy is a collection of cellular maintenance processes that act to recycle damaged structures in the cell, thereby maintaining cell health and function. On the one hand, the efficiency of autophagy declines with age, and this loss of function is associated with numerous age-related diseases, particularly of the central nervous system and its population of very long-lived neurons. On the other hand, increased autophagy is an important component of many of the interventions shown to slow aging in short-lived species, such as via calorie restriction. A fair number of research groups are working on ways to upregulate auto...
Source: Fight Aging! - Category: Research Authors: Tags: Medicine, Biotech, Research Source Type: blogs
Source: Chinese Journal of Integrative Medicine - Category: Internal Medicine Source Type: research
AbstractAs the worldwide population ages, the prevalence of Alzheimer's disease (AD) increases. However, the results of promising medications have been unsatisfactory. Chinese acupuncture has a long history of treating dementia, but lack of evidence from well-designed randomized controlled trials that validate its efficacy and safety, as well as its lack of clear underlying mechanisms, contribute to its limited application in clinical practice. In recent years, brain imaging technologies, such as functional magnetic resonance imaging and positron emission tomography, have been used to assess brain responses to acupuncture ...
Source: Chinese Journal of Integrative Medicine - Category: Internal Medicine Source Type: research
AbstractObjectiveTo assess the effect and safety of Huannao Yicong Formula ( 还脑益聪方, HYF) in the treatment of patients with mild-to-moderate Alzheimer’s disease (AD).MethodsSixty patients with mild-tomoderate AD were evenly randomized into HYF group and donepezil group with the random number method. Patients in the HYF group took 5 g of HYF granules twice daily and 5 mg placebo of donepezil once daily. Patients in the donepezil group took 5 mg donepezil once daily and 5 g placebo of HYF granules twice daily. The intervention lasted for 6 months. Clinical researchers, participants and statisticians were blind...
Source: Chinese Journal of Integrative Medicine - Category: Internal Medicine Source Type: research
Early studies point to Porphyromonas gingivalis, the bacteria linked to periodontal disease, as a possible causal culprit in Alzheimer's disease.Medscape Medical News
Source: Medscape Internal Medicine Headlines - Category: Internal Medicine Tags: Psychiatry News Source Type: news
CONCLUSION: Despite universal health coverage, patients with AD and a low individual SES in disadvantaged areas exhibited the worst survival rate. The socioeconomic survival gradient among patients with AD in Taiwan may result from differences in major attributes of individual and neighborhood SES. PMID: 31324380 [PubMed - as supplied by publisher]
Source: The American Journal of Geriatric Psychiatry - Category: Psychiatry Tags: Am J Geriatr Psychiatry Source Type: research
The words filled me with dread. But even then, I couldn't begin to imagine the trauma we would have to endure. My sister and I sold my dad's lovely tudor house in Shropshire for £350,000 to fund his care.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
This randomized clinical trial examines the effects, safety, and tolerability of AZD0530 medication in patients with mild Alzheimer disease.
Source: JAMA Neurology - Category: Neurology Source Type: research
This study will be the first clinical trial to identify the therapeutic potential ofKami Guibi-tang for amnestic MCI. The findings will provide insight into the feasibility of large-scale trials to gather evidence for KGT as a treatment for MCI.Trial registrationKorean Clinical Trial Registry, ID:KCT0002407. Registered on 30 March 2017.
Source: Trials - Category: Research Source Type: clinical trials
An eighteen-year-old Vancouver student has created a smartphone system that helps detect whether someone might have Alzheimer's disease.
Source: CBC | Health - Category: Consumer Health News Tags: News/Canada/British Columbia Source Type: news
More News: Alzheimer's | Geriatrics